| Amy Elizabeth O'neill, LCSW | |
|
5 Mareblu, Aliso Viejo, CA 92656-3014 | |
| (949) 643-6901 | |
| Not Available |
| Full Name | Amy Elizabeth O'neill |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 5 Mareblu, Aliso Viejo, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124110028 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Elizabeth O'neill, LCSW 5 Mareblu, Aliso Viejo, CA 92656-3014 Ph: (949) 643-6901 | Amy Elizabeth O'neill, LCSW 5 Mareblu, Aliso Viejo, CA 92656-3014 Ph: (949) 643-6901 |
News Archive
Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.
A study published Thursday in the Journal of the National Cancer Institute concluded that proton-beam therapy provided no long-term benefit over traditional radiation despite far higher costs.
In a new study, published recently on the bioRxiv preprint server, researchers isolated a nanobody that potently neutralizes SARS-CoV-2, including the B.1.351 variant, and cross-neutralizes SARS-CoV. They demonstrated the therapeutic potential of the nanobody in a human ACE2 (angiotensin-converting enzyme) transgenic mouse model.
A new review by David A. Walsh and Joanne Stocks in the September 2017 issue of SLAS Discovery (formerly the Journal of Biomolecular Screening) explores evolving treatments and future therapies for osteoarthritis (OA) pain.
QR Pharma, Inc., a clinical stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative disorders, announced today that Dr. Maria Maccecchini, CEO, will be presenting new data on its lead compound "Posiphen® Recovers Memory, Learning and Brain Function in Alzheimer Transgenic Mice" at the 12th Annual Biotech Symposium, taking place October 22, 2012 in Philadelphia, PA.
› Verified 8 days ago
Ms. Cynthia Elaine Roe, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24502 Pacific Park Dr, Aliso Viejo, CA 92656 Phone: 714-223-2604 | |
Gladys Y Newbury, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 19 Sea Pnes, Aliso Viejo, CA 92656 Phone: 818-445-0952 | |
Melody Garcia Paschen, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5 Mareblu Ste 100, Aliso Viejo, CA 92656 Phone: 949-643-6900 | |
Ms. Tal Gat, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5 Mareblu, Suite 100, Aliso Viejo, CA 92656 Phone: 949-643-6965 | |
Marie Miao, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 26895 Aliso Creek Rd Ste B-1013, Aliso Viejo, CA 92656 Phone: 949-630-0584 | |
Cary Brannon Clevenger, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5 Mareblu, Aliso Viejo, CA 92656 Phone: 949-643-6935 |